Hedge Fund · CIK 0001079114

David Einhorn

Greenlight Capital
Share

David Einhorn runs Greenlight Capital, a hedge fund overseeing $2.05B in disclosed equity holdings (SEC CIK 0001079114). The latest portfolio (2023Q4) discloses 40 positions across 8 sectors, with the largest positions in GRBK, CEIXEUR and BHF. On a mark-to-market basis the tracked portfolio has returned 80.9% over the past year. OpenStocks tracks 40 consecutive quarterly snapshots for this manager — every position change, new entry, and exit is logged below.

Portfolio
$2.05B
Positions
40
Quarter
2023Q4
Filings tracked
40
1Y+80.9%3Y-98.6%5Y-97.3%Full performance →
Biggest winner since filing
THCTENET HEALTHCARE CORP
+214.9%
+$172.4M
Biggest loser since filing
ALITALIGHT INC
-92.4%
−$72.9M

Investment strategy

David Einhorn is a mid-size fund with a concentrated portfolio tilted toward consumer names. 48% of the disclosed equity book is in consumer-facing sectors.

Embed this chart
Paste this iframe anywhere to embed the live GRBK chart.
<iframe src="https://openstocks.me/embed/stock/GRBK" width="100%" height="480" frameborder="0" loading="lazy" title="GRBK chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>

Holdings

8 sectors
40 positions
Top 3 = 47% of book · GRBK, CEIXEUR, BHF
View full portfolio →

Performance

vs SPY
40 quarters tracked
Mark-to-market portfolio growth vs SPY benchmark, with AUM and concentration history.
View performance →

Options & derivatives

No options
David Einhorn has no PUT or CALL positions disclosed for this quarter.
View options →

Activity & trades

Quarter-by-quarter
Last move 2023Q4
ADD COYA — and 4 more recent moves.
View activity →

Recent transactions

See full activity →
ADD
COYA THERAPEUTICS INC
+805,959
~$7.41 · 2023Q4
2024-02-14
ADD
DANIMER SCIENTIFIC INC
+131,890
~$1.02 · 2023Q4
2024-02-14
ADD
DHT HOLDINGS INC
+1,755,060
~$9.81 · 2023Q4
2024-02-14
SOLD
FINSERV ACQUISITION CORP II
78,750
~$0.03 · 2023Q4
2024-02-14
ADD
FIRST CTZNS BANCSHARES INC N
+1,510
~$1418.97 · 2023Q4
2024-02-14